These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 31129703)
1. Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects. Said RS; Mantawy EM; El-Demerdash E Naunyn Schmiedebergs Arch Pharmacol; 2019 Oct; 392(10):1225-1238. PubMed ID: 31129703 [TBL] [Abstract][Full Text] [Related]
2. Promising anti- cervical carcinoma and inflammatory agent, Resveratrol targets poly (ADP-ribose) polymerase 1 (PARP-1) induced premature ovarian failure with a potent enzymatic modulatory activity. Alharbi H; Alshehri AS; Ahmad M; Guo WW J Reprod Immunol; 2021 Apr; 144():103272. PubMed ID: 33465522 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol protects against cisplatin-induced ovarian and uterine toxicity in female rats by attenuating oxidative stress, inflammation and apoptosis. Ibrahim MA; Albahlol IA; Wani FA; Abd-Eltawab Tammam A; Kelleni MT; Sayeed MU; Abd El-Fadeal NM; Mohamed AA Chem Biol Interact; 2021 Apr; 338():109402. PubMed ID: 33587916 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1). Said RS; El-Demerdash E; Nada AS; Kamal MM Biochem Pharmacol; 2016 Mar; 103():140-50. PubMed ID: 26827941 [TBL] [Abstract][Full Text] [Related]
5. Zingerone ameliorates cisplatin-induced ovarian and uterine toxicity via suppression of sex hormone imbalances, oxidative stress, inflammation and apoptosis in female wistar rats. Kaygusuzoglu E; Caglayan C; Kandemir FM; Yıldırım S; Kucukler S; Kılınc MA; Saglam YS Biomed Pharmacother; 2018 Jun; 102():517-530. PubMed ID: 29587238 [TBL] [Abstract][Full Text] [Related]
6. Progesterone decreases the extent of ovarian damage caused by cisplatin in an experimental rat model. Ozdamar S; Taskin MI; Onder GO; Kaymak E; Baran M; Yay A Adv Clin Exp Med; 2019 Jan; 28(1):25-33. PubMed ID: 30066501 [TBL] [Abstract][Full Text] [Related]
7. Cilostazol protects against cyclophosphamide-induced ovarian toxicity in female rats: role of cAMP and HO-1. Abdel-Aziz AM; Mohamed ASM; Abdelazem O; Okasha AMM; Kamel MY Toxicol Mech Methods; 2020 Sep; 30(7):526-535. PubMed ID: 32456565 [No Abstract] [Full Text] [Related]
8. Co-administration of either curcumin or resveratrol with cisplatin treatment decreases hepatotoxicity in rats Ramadan OI; S Ali L; M Abd-Allah F; E A Ereba R; S Humeda H; A Damanhory A; E Moustafa A; M Younes A; M Y Awad M; A A Omar N PeerJ; 2024; 12():e17687. PubMed ID: 39056050 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: Emphasis on TGF-β/MAPKs signaling pathway. Mantawy EM; Said RS; Abdel-Aziz AK Biomed Pharmacother; 2019 Jan; 109():293-303. PubMed ID: 30396087 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol improves sperm parameter and testicular apoptosis in cisplatin-treated rats: Effects on ERK1/2, JNK, and Akt pathways. Shati AA Syst Biol Reprod Med; 2019 Jun; 65(3):236-249. PubMed ID: 30507263 [TBL] [Abstract][Full Text] [Related]
11. Ovario-protective effects of genistein against cyclophosphamide toxicity in rats: Role of anti-müllerian hormone and oestradiol. Saleh DO; Mansour DF Eur J Pharmacol; 2016 Oct; 789():163-171. PubMed ID: 27448503 [TBL] [Abstract][Full Text] [Related]
12. S-Allylmercaptocysteine Attenuates Cisplatin-Induced Nephrotoxicity through Suppression of Apoptosis, Oxidative Stress, and Inflammation. Zhu X; Jiang X; Li A; Zhao Z; Li S Nutrients; 2017 Feb; 9(2):. PubMed ID: 28230744 [TBL] [Abstract][Full Text] [Related]
13. Dose dependent effect of resveratrol in preventing cisplatin-induced ovarian damage in rats: An experimental study. Atli M; Engin-Ustun Y; Tokmak A; Caydere M; Hucumenoglu S; Topcuoglu C Reprod Biol; 2017 Sep; 17(3):274-280. PubMed ID: 28716446 [TBL] [Abstract][Full Text] [Related]
14. Gonadotropin stimulation as a challenge to calibrate cisplatin induced ovarian damage in the female rat. Yeh J; Kim BS; Liang YJ; Peresie J Reprod Toxicol; 2009 Dec; 28(4):556-62. PubMed ID: 19737607 [TBL] [Abstract][Full Text] [Related]
15. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade. Tomar A; Vasisth S; Khan SI; Malik S; Nag TC; Arya DS; Bhatia J Phytomedicine; 2017 Oct; 34():154-161. PubMed ID: 28899498 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of resveratrol in improving ovarian function in a rat model of premature ovarian insufficiency. Li N; Liu L J Obstet Gynaecol Res; 2018 Aug; 44(8):1431-1438. PubMed ID: 29851197 [TBL] [Abstract][Full Text] [Related]
17. Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Khan R; Khan AQ; Qamar W; Lateef A; Tahir M; Rehman MU; Ali F; Sultana S Toxicol Appl Pharmacol; 2012 Feb; 258(3):315-29. PubMed ID: 22155348 [TBL] [Abstract][Full Text] [Related]
18. Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage? Özcan P; Fıçıcıoğlu C; Kizilkale O; Yesiladali M; Tok OE; Ozkan F; Esrefoglu M J Assist Reprod Genet; 2016 Sep; 33(9):1223-30. PubMed ID: 27255570 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague-Dawley rats. Özcan P; Fıçıcıoğlu C; Yıldırım ÖK; Özkan F; Akkaya H; Aslan İ Reprod Biomed Online; 2015 Sep; 31(3):404-10. PubMed ID: 26206282 [TBL] [Abstract][Full Text] [Related]
20. Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1. Mahran YF; El-Demerdash E; Nada AS; Ali AA; Abdel-Naim AB Endocrinology; 2013 Oct; 154(10):3888-99. PubMed ID: 23798597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]